Organon OGN Ratios (2020-2026)

NYSE OGN
$13.89 +0.00 (+0.00%)
As of: Nov 11, 2026 · 3:59 PM EST
Reported Financials

Organon Quarterly Ratios

Periods 27 quarters
Latest Sep 2026

Organon reported a gross margin of 55.21% and a net margin of 10.42% for the quarter ended Sep 2026. These financial ratios cover 27 quarters of results from Mar 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Profitability
Gross Margin
62.63%64.20%62.90%64.15%60.00%62.29%60.20%59.71%57.26%59.00%58.43%58.34%56.28%55.58%54.83%53.50%49.17%53.63%54.36%55.21%
EBT Margin
14.72%28.21%18.11%18.35%7.47%15.28%15.80%5.27%6.51%14.55%14.62%13.08%8.10%6.68%14.37%15.17%-9.82%14.59%11.75%16.20%
EBIT Margin
25.70%34.40%29.53%25.37%15.49%23.86%24.19%14.09%14.58%22.63%24.02%24.65%18.09%15.80%20.33%22.35%13.93%16.10%20.73%23.19%
EBITDA Margin
29.57%37.78%32.68%29.08%18.99%27.57%27.80%18.10%18.34%26.63%28.13%29.01%22.93%21.35%25.91%28.09%20.31%21.99%25.87%28.40%
Operating Margin
25.70%34.40%29.53%25.37%15.49%23.86%24.19%14.09%14.58%22.63%24.02%24.65%18.09%15.80%20.33%22.35%13.93%16.10%20.73%23.19%
Net Margin
12.60%22.21%14.76%14.77%7.27%11.51%15.05%3.82%34.17%12.39%12.13%22.69%6.85%5.75%9.10%9.99%-13.60%10.00%6.93%10.42%
FCF Margin
-0.75%5.74%6.69%17.05%13.74%4.42%-2.74%13.56%19.90%1.85%18.67%6.26%21.04%2.84%11.36%13.61%6.37%12.88%4.17%20.71%
Efficiency
Inventory AverageInventory Avg.
916.50M930.50M948.00M914.50M941.00M1,062.00M1,160.00M1,192.50M1,250.50M1,289.00M1,275.00M1,335.00M1,352.00M1,341.50M1,408.00M1,471.00M1,447.00M1,389.50M1,362.00M1,353.00M
Assets AverageAssets Avg.
11,008.00M10,639.00M10,605.50M10,525.50M10,696.00M10,859.00M10,871.00M10,995.50M11,535.00M11,974.50M12,022.50M12,453.00M12,926.50M13,128.50M13,328.00M13,526.00M13,209.50M12,931.50M13,087.00M13,289.50M
Equity AverageEquity Avg.
-1,563.00M-1,379.00M-1,193.50M-1,101.50M-979.00M-814.50M-646.00M-572.00M-329.50M-11.00M96.00M318.50M482.50M507.00M637.50M819.50M829.00M827.50M954.50M1,099.50M
Invested CapitalInvested Cap.
7,626.00M7,844.00M7,756.00M7,633.00M8,021.00M7,974.00M8,175.00M8,065.00M8,690.00M8,762.00M8,800.00M9,242.00M9,352.00M9,498.00M9,629.00M9,734.00M9,396.00M9,472.00M9,559.00M9,747.00M
Asset Utilization RatioAsset Util.
0.570.600.600.600.580.570.570.560.540.530.530.510.500.480.470.470.470.480.470.46
Leverage & Solvency
Interest Coverage RatioInterest Cover
4.205.564.783.611.932.782.951.601.812.802.953.102.181.932.472.801.742.122.993.44
Debt Ratio
0.860.860.840.830.810.810.800.790.730.730.710.690.680.680.660.650.670.660.650.64
Times Interest Earned
4.205.564.783.611.932.782.951.601.812.802.953.102.181.932.472.801.742.122.993.44
Valuation
Price to EarningsP/E
5.726.827.755.897.758.027.057.593.604.595.333.794.455.123.595.549.986.4017.0116.90
Price to SalesP/S
1.231.391.350.951.150.970.860.720.590.760.840.770.600.610.400.440.300.260.580.59
Price to BookP/B
100.2137.019.998.157.093.433.062.481.743.533.02
Enterprise Value
6,986.25M8,165.55M8,038.33M5,453.12M6,398.55M5,525.24M4,992.37M4,023.32M2,993.13M4,234.92M4,625.69M4,163.72M3,171.36M3,293.88M1,917.46M2,104.62M1,292.47M457.27M2,423.73M2,145.55M
EV to EBIT
3.654.114.153.013.933.803.633.352.493.523.853.032.222.531.551.741.140.412.151.89
EV to EBITDA
3.323.723.742.683.483.313.122.822.082.933.192.551.862.061.231.360.870.311.641.45
Market Capitalization
7,723.25M8,859.55M8,583.33M5,952.12M7,104.55M5,984.24M5,318.37M4,437.32M3,686.13M4,809.92M5,329.69M4,926.72M3,846.36M3,840.88M2,516.46M2,776.62M1,866.47M1,573.27M3,555.73M3,600.55M
Price to FCFP/FCF
3.9211.1316.6313.3510.739.3510.8510.226.739.436.246.605.034.943.823.573.472.306.275.33
EV to FCF
3.5510.2615.5812.239.678.6310.199.275.468.305.425.574.154.242.912.712.400.674.273.18
EV to CFO
3.238.3111.678.557.466.516.896.013.755.564.344.403.383.512.322.221.850.543.292.55
Return Ratios
Return on Sales [ROS]ROS
25.70%34.40%29.53%25.37%15.49%23.86%24.19%14.09%14.58%22.63%24.02%24.65%18.09%15.80%20.33%22.35%13.93%16.10%20.73%23.19%
Return on Capital Employed [ROCE]ROCE
22.73%23.83%23.57%22.07%19.88%17.09%16.22%14.11%13.96%12.76%12.95%14.24%14.02%12.39%11.78%11.15%10.45%10.80%10.75%10.65%
Return on Invested Capital [ROIC]ROIC
22.08%22.26%20.28%19.06%16.99%14.83%14.57%12.71%14.36%13.79%13.67%15.25%15.39%13.82%12.98%8.91%5.20%5.47%5.04%4.97%
Return on Assets [ROA]ROA
12.27%12.22%10.44%9.61%8.57%6.87%6.94%5.32%8.87%8.74%8.32%10.45%6.68%5.71%5.25%3.70%1.42%1.90%1.60%1.60%
Return on Equity [ROE]ROE
1,041.67%408.48%179.07%147.93%109.80%61.13%22.56%29.73%21.90%19.37%

Organon Ratios API

Pull Organon's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=OGN&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY